NewswireToday - /newswire/ -
Noida, Uttar Pradesh, India, 2011/05/19 - Consistently high and rising healthcare costs in the country and related government support is expected to boost the growth of the US generics market during 2010-2013, says RNCOS - RNCOS.com.
As per our new research report “Booming US Generic Drug Market”, high healthcare costs in the country has raised a lot concerns in the Government, and the regulatory authorities are shifting their support towards generics industry to help curb the costs. Apart from this, the generics industry is also receiving a boost from the several patent expirations lined up for blockbuster drugs during the next few years. On the back of this, many generic companies have already lined up the generic versions of these blockbuster drugs to be introduced in the market as soon as the patent is lifted. Along with these factors, revival of the country’s economy and increasing per capita income of the people will also help the generics market to grow at a CAGR of 10% during 2010-2013.
Through in depth research and prudent analysis of the industry, we have identified that, the new government reforms making health insurance compulsory will also support the generics industry. The hospital sector will also come forth as a top consumer of these generics, especially to treat people with less fortunate financial conditions. The report also covers prominent factors, which will act as a catalyst for the industry’s current and future growth outlook.
Our report also includes a pragmatic study of the potential of generic drugs in various therapeutics segments of the pharmaceutical industry, which will give a clear idea about the type of products available in the market. Moreover, overview of the regulatory environment regarding pharmaceutical industry in the country will help in the identification of the supportive factors for the generics market. Besides, the report also discusses several industry bottlenecks that are blocking the growth of generics industry in the country.
The report,“Booming US Generic Drug Market”, covers various growth-supporting factors, such as macroeconomic environment, healthcare reform plans, and its impact and other growth supporting factors. The report thoroughly examines the current market trends; industrial developments, and competitive landscape to enable clients understand the market structure and its progress in coming years. Forecast in this research has been prepared considering the possible post-recession impact on the industry.
RNCOS (rncos.com) specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals study and analyze the industry and its various components, with comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the consultants in meeting their objectives in a cost-effective and timely manner.